LAVA Therapeutics NV Comprehensive Income
LAVA Therapeutics NV reported Comprehensive Income of -$7.64 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-11-06
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.64M.
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$6.29M.
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$2.50M.
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$5.89M.
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$26.87M.
- LAVA Therapeutics NV comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$39.80M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$7.64M 10-Q · filed 2025-11-06 | -$13.93M derived: sum of 2 quarters · filed 2025-11-06 | -$16.43M 10-Q · filed 2025-11-06 | -$22.32M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$6.29M 10-Q · filed 2025-08-13 | -$8.79M 10-Q · filed 2025-08-13 | -$14.68M derived: sum of 3 quarters · filed 2025-08-13 | -$25.28M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$2.50M 10-Q · filed 2025-05-14 | -$8.39M derived: sum of 2 quarters · filed 2025-05-14 | -$18.99M derived: sum of 3 quarters · filed 2025-11-06 | -$27.72M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$16.49M derived: sum of 2 quarters · filed 2025-11-06 | -$25.22M derived: sum of 3 quarters · filed 2025-11-06 | -$26.87M 10-K · filed 2025-03-28 |
| 2024-09-30 | -$10.61M 10-Q · filed 2025-11-06 | -$19.33M derived: sum of 2 quarters · filed 2025-11-06 | -$20.98M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$8.72M 10-Q · filed 2025-08-13 | -$10.38M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.66M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$39.80M 10-K · filed 2025-03-28 |